Menarini News

The acquisition of US company Stemline Therapeutics: a brave move that rewards Menarini at M&A Award 2021

2020 has been an unprecedentedly arduous year around the world. Many industrial sectors – including pharmaceuticals and healthcare – have been affected by the pandemic. In such a delicate context, undertaking a $677 million operation by purchasing 100% of the shares of a major US biopharmaceutical company was a bold move, that allowed Menarini Group []

trending_flat Read more

“Telltale” cells in the blood to fight Coronavirus: Fondazione Menarini organises an online congress together with the scientific community

The Menarini International Foundation at the forefront of promoting the culture of prevention and scientific education on COVID-19. A simple blood test could help detect which patients are most at risk of developing serious forms of COVID-19 beforehand. This is the purpose of an experimental study underway at the University of Milan Luigi Sacco Hospital []

trending_flat Read more

Menarini lands in America acquiring the biopharmaceutical company Stemline Therapeutics Inc.

Menarini acquires the U.S. biopharmaceutical company Stemline Therapeutics, focused on the development and commercialization of novel oncology therapeutics. The transaction for this Company – previously listed on Nasdaq – was already announced in early May 2020 and then completed in early June for an aggregate cash consideration up to $ 677 million. Menarini in America []

trending_flat Read more